Genomic Vision: Postponement of the ordinary general meeting of shareholders of June 28, 2022

BAGNEUX, France, June 27, 2022–(BUSINESSWIRE)–Regulatory News: Genomic Vision (FR0011799907 – GV, PEA-PME eligible – the “Company”) (Paris:GV)a biotechnology company that develops tools and services dedicated to the analysis and control of genome modifications, informs its shareholders that, in view of the requests for admission cards, postal voting forms and proxies received at today by the … Read more